tradingkey.logo
tradingkey.logo
Search

Telomir Pharmaceuticals Inc

TELO
Add to Watchlist
1.099USD
+0.009+0.87%
Market hours ETQuotes delayed by 15 min
75.62MMarket Cap
LossP/E TTM

TELO Balance Sheet

You can check out the annual or quarterly balance sheets of Telomir Pharmaceuticals Inc here to evaluate the financial health, analyze fundamentals, and calculate key ratios for liquidity, leverage, and return on equity.
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q2
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
Total equity
Cash, cash equivalents and short-term investments
585.42%5.17M
1279.78%5.56M
475.51%7.29M
778.14%7.33M
-59.96%754.32K
-87.69%403.00K
102753.86%1.27M
33939.07%834.64K
12777.91%1.88M
--3.27M
--1.23K
--2.45K
--14.63K
- Cash and cash equivalents
585.42%5.17M
1279.78%5.56M
475.51%7.29M
778.14%7.33M
-59.96%754.32K
-87.69%403.00K
102753.86%1.27M
33939.07%834.64K
12777.91%1.88M
--3.27M
--1.23K
--2.45K
--14.63K
Receivables
----
----
----
----
----
----
----
0.00%130.00K
--130.00K
--130.00K
--130.00K
--130.00K
----
-Other receivables
----
----
----
----
----
----
----
0.00%130.00K
--130.00K
--130.00K
--130.00K
--130.00K
----
Prepaid expenses
419.65%391.24K
159.70%229.03K
-5.50%54.69K
-5.85%72.82K
-14.26%75.29K
-10.75%88.19K
8016.97%57.87K
7931.88%77.35K
--87.81K
--98.81K
--713.00
--963.00
----
Other current assets
----
----
--0.00
--0.00
----
--0.00
----
----
----
--0.00
--303.28K
--102.89K
--81.44K
Total current assets
----
1078.68%5.79M
454.48%7.34M
610.39%7.40M
-60.53%829.61K
-85.98%491.19K
204.21%1.32M
340.94%1.04M
2087.79%2.10M
--3.50M
--435.23K
--236.31K
--96.07K
Non-current assets
Other non-current assets
----
----
----
----
----
----
----
----
-100.00%0.00
--0.00
--4.34M
--5.08M
--5.83M
Total non-current assets
----
----
----
----
----
----
----
----
-100.00%0.00
--0.00
--4.34M
--5.08M
--5.83M
Total assets
546.80%5.37M
1078.68%5.79M
454.48%7.34M
610.39%7.40M
-60.53%829.61K
-85.98%491.19K
-72.26%1.32M
-80.41%1.04M
-64.51%2.10M
--3.50M
--4.77M
--5.32M
--5.92M
Liabilities
Current liabilities
-Other payables
----
269.07%344.83K
407.06%473.75K
0.00%93.43K
-33.43%93.43K
-63.73%93.43K
-82.28%93.43K
-92.85%93.43K
22572.21%140.34K
--257.63K
--527.38K
--1.31M
--619.00
Accrued expenses
----
----
--417.47K
----
----
----
----
----
----
--7.36K
----
----
----
Short-term debt and lease liabilities
--136.37K
--202.87K
----
----
----
----
----
----
-100.00%0.00
--0.00
--101.00K
--1.34M
--487.91K
-Short-term debt
--136.37K
--202.87K
----
----
----
----
----
----
-100.00%0.00
--0.00
--101.00K
--1.34M
--487.91K
Other current liabilities
----
269.07%344.83K
407.06%473.75K
0.00%93.43K
-33.43%93.43K
-63.73%93.43K
-82.28%93.43K
-92.85%93.43K
22572.21%140.34K
--257.63K
--527.38K
--1.31M
--619.00
Total current liabilities
----
26.83%827.31K
109.70%1.43M
-29.52%422.81K
-34.78%348.39K
34.06%652.29K
-49.01%680.97K
-80.90%599.91K
-73.72%534.15K
--486.55K
--1.34M
--3.14M
--2.03M
Non-current liabilities
Long-term debt and lease liabilities
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
Other non-current liabilities
----
--0.00
--0.00
--0.00
----
--0.00
----
----
----
----
----
----
----
Total liabilities
-4.58%332.42K
26.83%827.31K
109.70%1.43M
-29.52%422.81K
-34.78%348.39K
34.06%652.29K
-49.01%680.97K
-80.90%599.91K
-73.72%534.15K
--486.55K
--1.34M
--3.14M
--2.03M
Shareholders' equity
Common equity
27.21%48.76M
43.99%46.96M
50.20%46.92M
63.21%45.93M
64.25%38.33M
39.77%32.62M
78.49%31.24M
306.95%28.14M
237.46%23.34M
--23.34M
--17.50M
--6.92M
--6.92M
Retained earnings
-15.53%-43.72M
-28.14%-42.00M
-34.03%-41.01M
-40.62%-38.95M
-73.87%-37.85M
-61.31%-32.78M
-117.55%-30.60M
-484.74%-27.70M
-619.45%-21.77M
---20.32M
---14.06M
---4.74M
---3.03M
Capital reserves
27.21%48.76M
43.99%46.96M
50.20%46.92M
63.21%45.93M
64.25%38.33M
39.77%32.62M
78.49%31.24M
306.95%28.14M
237.46%23.34M
--23.34M
--17.50M
--6.92M
--6.92M
Total equity
945.98%5.03M
3180.10%4.96M
819.60%5.91M
1478.77%6.98M
-69.30%481.22K
-105.34%-161.11K
-81.30%643.04K
-79.70%442.07K
-59.70%1.57M
--3.02M
--3.44M
--2.18M
--3.89M
Currency unit
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
Audit opinions
----
----
----
----
----
----
----
----
----
----
----
----
----

FAQs

Which balance sheet metrics matter most when analyzing TELO stock?

Important metrics include cash and short-term investments, total assets, current assets, total liabilities, current liabilities, long-term debt, shareholders' equity, retained earnings, inventory, receivables, working capital, current ratio, quick ratio, debt-to-equity ratio, and return on equity. Investors usually review these together rather than relying on one number.

What is the difference between assets, liabilities, and shareholders' equity?

Assets are resources the company owns or controls, such as cash, receivables, inventory, investments, and property. Liabilities are obligations the company owes, such as accounts payable, debt, leases, and taxes. Shareholders' equity is the residual value after liabilities are subtracted from assets.

What is the difference between current and non-current items?

Current assets and current liabilities are generally expected to be converted, used, paid, or settled within one year or one operating cycle. Non-current assets and non-current liabilities are longer-term items, such as property, long-term investments, deferred tax assets, long-term debt, and lease obligations.

How Much Cash Does Telomir Pharmaceuticals Inc Have?

In its most recent quarterly, Telomir Pharmaceuticals Inc had 5.17M in cash and cash equivalents.

How Much Shareholders' Equity Does Telomir Pharmaceuticals Inc Have?

Telomir Pharmaceuticals Inc reported 5.91M in total shareholders' equity as of the latest reported quarter.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.